Richard A. Basile,Co-Founder and CEO of BioPontis Alliance for Rare Diseases, discusses the challenges of developing drugs for rare diseases.

BioPontis is an international nonprofit organization whose mission is to advance promising science into potential treatments for rare neurological diseases.

BioPontis Alliance for Rare Diseases is dedicated to the development of new therapeutic agents to treat rare diseases. The niche philanthropy uses a collaborative approach, partnering with patient organizations and academic researchers. BioPontis provides the plans and executes the preclinical translational scientific, early clinical development, patenting, and business relationship management. We bring the expertise that is needed to advance ideas for treatments into drug compounds that are ready for uptake by the biopharmaceutical and biotech industry.